Emerald Advisers’s Zimmer Biomet ZBH Stock Holding History

Emerald Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,820	Closed	-$211K	–	360
2020 Q2	$211K	Buy	+1,820	New	+$210K	0.01%	217
2020 Q1	–	Sell	-1,950	Closed	-$283K	–	324
2019 Q4	$283K	Sell	1,950 -42	-2%	-$5.8K	0.01%	218
2019 Q3	$265K	Sell	1,992 -393	-16%	-$50.8K	0.01%	218
2019 Q2	$273K	Sell	2,385 -1,122	-32%	-$131K	0.01%	221
2019 Q1	$435K	Sell	3,507 -19	-0.5%	-$2.16K	0.02%	203
2018 Q4	$355K	Sell	3,526 -772	-18%	-$86.8K	0.02%	207
2018 Q3	$549K	Sell	4,298 -146	-3%	-$17.4K	0.02%	204
2018 Q2	$481K	Sell	4,444 -142	-3%	-$15.5K	0.02%	209
2018 Q1	$485K	Buy	+4,586	New	+$533K	0.02%	210
2017 Q3	–	Sell	-4,349	Closed	-$542K	–	253
2017 Q2	$542K	Sell	4,349 -14,671	-77%	-$1.74M	0.02%	193
2017 Q1	$2.25M	Sell	19,020 -7,891	-29%	-$894K	0.09%	151
2016 Q4	$2.7M	Buy	+26,911	New	+$2.88M	0.12%	137

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Emerald Advisers's ZBH Position: Q3 2020 in Review

Emerald Advisers sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 1,820 shares — an estimated $211K sold.

Emerald Advisers first reported a position in ZBH in Q4 2016 and held it in 12 quarters. The position peaked at $2.7M in Q4 2016. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Emerald Advisers reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
Emerald Advisers sold 1,820 Zimmer Biomet shares in Q3 2020, an estimated $211K.
Emerald Advisers first reported a position in Zimmer Biomet in Q4 2016 and held it in 12 quarters.
Emerald Advisers's Zimmer Biomet position peaked at $2.7M in Q4 2016.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Emerald Advisers's 13F filing for Q3 2020, filed 28 Oct 2020.